Dr Sulaiman Al Habib Medical Services (4013) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 reached SAR 3,158 million (SR 3.16 billion), up 25.2% year-over-year.

• Net income for Q1 2025 was SAR 579.8 million, a 1.3% increase year-over-year.

• Opened two new hospitals (Hamra in Riyadh and Khobar Medical Center), expanding geographic footprint and capacity.

• Interim dividends of SAR 1.23 per share (SAR 430.5 million total) were declared for Q1 2025.

• Total assets grew to SAR 21.36 billion as of March 31, 2025.

Financial highlights

• Gross profit increased to SAR 1,028 million (SR 1.03 billion), up from SAR 877 million year-over-year; gross margin at 32.6%.

• EBITDA reached SAR 816 million, up 19.8%; EBITDA margin at 25.8%.

• Operating income increased to SAR 625.9 million from SAR 556.1 million in Q1 2024.

• Basic and diluted EPS was SAR 1.59, compared to SAR 1.57 in Q1 2024.

• Cash and cash equivalents at period end were SAR 2,548 million.

Outlook and guidance

• Robust expansion plans with multiple new hospitals opening in 2025 and beyond.

• Focus on operational efficiency, digital transformation, and sustainable growth.

• Management notes that interim results may not reflect full-year performance.